CLINICAL_TRIALS
trial_result
· 2015-10-19
Clinical Trial Update: Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD) [Phase 3]
Summary
Phase III study of idebenone for Duchenne muscular dystrophy has completed and results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Santhera Pharmaceuticals | Conditions: Muscular Dystrophy, Duchenne, Ambulatory Care | Phase 3 | Status: COMPLETED | Results posted: 2015-10-19